Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30


Preoperative Radiographic Assessment Predicts Incomplete Cytoreduction in Patients with Low Grade Mucinous Adenocarcinoma of the Appendix.

Sabesan A, Felder S, Feuerlein S, Lam C, McGettigan M, Powers BD, Dessureault S, Dineen SP.

Ann Surg Oncol. 2020 Jan;27(1):165-170. doi: 10.1245/s10434-019-07676-2. Epub 2019 Aug 6.


Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.

Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ.

Ann Surg Oncol. 2019 Jul;26(7):2234-2240. doi: 10.1245/s10434-019-07373-0. Epub 2019 Apr 23.


A Survey of the Complex General Surgical Oncology Fellowship Programs Regarding Applicant Selection and Rank.

Wach MM, Ayabe RI, Ruff SM, D'Angelica M, Dineen SP, Grubbs EG, Shibata D, Shirley L, Weiss MJ, Davis JL, Hernandez JM.

Ann Surg Oncol. 2019 Sep;26(9):2675-2681. doi: 10.1245/s10434-019-07372-1. Epub 2019 Apr 22.


Comment on: External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix.

Dineen SP, Royal RE, Mansfield PF, Fournier KF.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):627. doi: 10.1245/s10434-017-6218-3. Epub 2017 Nov 9. No abstract available.


Failure to operate on resectable gastric cancer: implications for policy changes and regionalization.

Frohman HA, Martin JT, Le AT, Dineen SP, Tzeng CD.

J Surg Res. 2017 Jun 15;214:229-239. doi: 10.1016/j.jss.2017.03.043. Epub 2017 Mar 31.


Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer.

Le AT, Huang B, Hnoosh D, Saeed H, Dineen SP, Hosein PJ, Durbin EB, Kudrimoti M, McGrath PC, Tzeng CD.

J Surg Res. 2017 Jun 15;214:1-8. doi: 10.1016/j.jss.2017.02.036. Epub 2017 Mar 18.


Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis.

Saeed H, Hnoosh D, Huang B, Durbin EB, McGrath PC, Desimone P, Maynard E, Anthony LB, Dineen SP, Hosein PJ, Tzeng CW.

J Surg Oncol. 2016 Sep;114(4):451-5. doi: 10.1002/jso.24314. Epub 2016 May 30.


Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.

Roland CL, May CD, Watson KL, Al Sannaa GA, Dineen SP, Feig R, Landers S, Ingram DR, Wang WL, Guadagnolo BA, Feig B, Hunt KK, Cormier JN, Lazar AJ, Torres KE.

Ann Surg Oncol. 2016 Jul;23(7):2220-8. doi: 10.1245/s10434-016-5115-5. Epub 2016 Feb 3.


Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates.

Dineen SP, Robinson KA, Roland CL, Beaty KA, Rafeeq S, Mansfield PF, Royal RE, Fournier KF.

J Surg Res. 2016 Jan;200(1):158-63. doi: 10.1016/j.jss.2015.08.003. Epub 2015 Aug 13.


Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.

Kirane A, Ludwig KF, Sorrelle N, Haaland G, Sandal T, Ranaweera R, Toombs JE, Wang M, Dineen SP, Micklem D, Dellinger MT, Lorens JB, Brekken RA.

Cancer Res. 2015 Sep 15;75(18):3699-705. doi: 10.1158/0008-5472.CAN-14-2887-T. Epub 2015 Jul 23.


Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.

Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Sannaa GA, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, Torres KE.

Ann Surg Oncol. 2015 Nov;22(12):3913-20. doi: 10.1245/s10434-015-4453-z. Epub 2015 Mar 6.


A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.

Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF.

Ann Surg Oncol. 2015 Oct;22(11):3640-6. doi: 10.1245/s10434-015-4446-y. Epub 2015 Feb 20.


Clostridium difficile enteritis: A report of two cases and systematic literature review.

Dineen SP, Bailey SH, Pham TH, Huerta S.

World J Gastrointest Surg. 2013 Mar 27;5(3):37-42. doi: 10.4240/wjgs.v5.i3.37.


Primary pericardial mesothelioma in a 19-year-old presenting as pericarditis.

Kayatta MO, Dineen SP, Sica G, Puskas JD, Pickens A.

Ann Thorac Surg. 2013 Aug;96(2):680-1. doi: 10.1016/j.athoracsur.2013.01.035. Epub 2013 Jan 23.


Clonal analysis reveals a common progenitor for endothelial, myeloid, and lymphoid precursors in umbilical cord blood.

Ramos AL, Darabi R, Akbarloo N, Borges L, Catanese J, Dineen SP, Brekken RA, Perlingeiro RC.

Circ Res. 2010 Dec 10;107(12):1460-9. doi: 10.1161/CIRCRESAHA.110.223669. Epub 2010 Oct 14.


Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.

Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW.

J Clin Invest. 2010 Jul;120(7):2319-30. doi: 10.1172/JCI38291. Epub 2010 Jun 23.


Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts.

Roland CL, Dineen SP, Toombs JE, Carbon JG, Smith CW, Brekken RA, Barnett CC Jr.

Exp Biol Med (Maywood). 2010 Feb;235(2):263-70. doi: 10.1258/ebm.2009.009215.


Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.

Dineen SP, Roland CL, Greer R, Carbon JG, Toombs JE, Gupta P, Bardeesy N, Sun H, Williams N, Minna JD, Brekken RA.

Cancer Res. 2010 Apr 1;70(7):2852-61. doi: 10.1158/0008-5472.CAN-09-3892. Epub 2010 Mar 23.


Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Arnold SA, Rivera LB, Miller AF, Carbon JG, Dineen SP, Xie Y, Castrillon DH, Sage EH, Puolakkainen P, Bradshaw AD, Brekken RA.

Dis Model Mech. 2010 Jan-Feb;3(1-2):57-72. doi: 10.1242/dmm.003228. Epub 2009 Dec 9.


Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.

Roland CL, Lynn KD, Toombs JE, Dineen SP, Udugamasooriya DG, Brekken RA.

PLoS One. 2009 Nov 3;4(11):e7669. doi: 10.1371/journal.pone.0007669.


Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.

Roland CL, Dineen SP, Lynn KD, Sullivan LA, Dellinger MT, Sadegh L, Sullivan JP, Shames DS, Brekken RA.

Mol Cancer Ther. 2009 Jul;8(7):1761-71. doi: 10.1158/1535-7163.MCT-09-0280. Epub 2009 Jun 30.


Can medical students achieve skills proficiency through simulation training?

Naylor RA, Hollett LA, Valentine RJ, Mitchell IC, Bowling MW, Ma AM, Dineen SP, Bruns BR, Scott DJ.

Am J Surg. 2009 Aug;198(2):277-82. doi: 10.1016/j.amjsurg.2008.11.036. Epub 2009 Apr 10.


Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison.

Dineen SP, Roland CL, Schwarz RE.

HPB Surg. 2008;2008:719459. doi: 10.1155/2008/719459. Epub 2009 Jan 29.


The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.

Dineen SP, Sullivan LA, Beck AW, Miller AF, Carbon JG, Mamluk R, Wong H, Brekken RA.

BMC Cancer. 2008 Nov 27;8:352. doi: 10.1186/1471-2407-8-352.


The acellular fraction of stored platelets promotes tumor cell invasion.

Dineen SP, Roland CL, Toombs JE, Kelher M, Silliman CC, Brekken RA, Barnett CC Jr.

J Surg Res. 2009 May 1;153(1):132-7. doi: 10.1016/j.jss.2008.04.013. Epub 2008 May 7.


Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.

Dineen SP, Lynn KD, Holloway SE, Miller AF, Sullivan JP, Shames DS, Beck AW, Barnett CC, Fleming JB, Brekken RA.

Cancer Res. 2008 Jun 1;68(11):4340-6. doi: 10.1158/0008-5472.CAN-07-6705.


A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity.

Udugamasooriya DG, Dineen SP, Brekken RA, Kodadek T.

J Am Chem Soc. 2008 Apr 30;130(17):5744-52. doi: 10.1021/ja711193x. Epub 2008 Apr 2.


Supplemental Content

Loading ...
Support Center